The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/Ib study of the aurora kinase A inhibitor alisertib in combination with osimertinib in advanced osimertinib-resistant EGFR-mutated lung cancer.
 
Turja Chakrabarti
No Relationships to Disclose
 
Greg M. Allen
No Relationships to Disclose
 
Matthew A. Gubens
Consulting or Advisory Role - Anheart Therapeutics; AstraZeneca; Atreca; Bristol Myers Squibb; Cardinal Health; Genentech/Roche; Genzyme; Gilead Sciences; Guardant Health; InVitae; ITeos Therapeutics; Merus; Sanofi; Summit Therapeutics; Surface Oncology
Research Funding - Amgen (Inst); Celgene (Inst); Genentech/Roche (Inst); Johnson & Johnson/Janssen (Inst); Merck (Inst); Novartis (Inst); OncoMed (Inst); Trizell (Inst)
 
Claire Mulvey
Honoraria - OncLive/MJH Life Sciences
Consulting or Advisory Role - Jazz Pharmaceuticals
Research Funding - Genentech
 
Ana I. Velazquez Manana
Stock and Other Ownership Interests - Corbus Pharmaceuticals
Honoraria - Curio Science; Guidepoint Pharmacy; MDOutlook; MJH Life Sciences
Consulting or Advisory Role - AstraZeneca; Merus NV; Novocure; Regeneron
Travel, Accommodations, Expenses - DAVA Oncology
Other Relationship - Pfizer
 
Wei Wu
No Relationships to Disclose
 
Megan Gee
No Relationships to Disclose
 
Lisa Tan
No Relationships to Disclose
 
Trever G. Bivona
Stock and Other Ownership Interests - Granule Therapeutics, Relay, Revolution Medicines, Rain
Honoraria - Relay, Revolution Medicines, Rain
Consulting or Advisory Role - Relay, Revolution Medicines, Rain, Engine, Novartis, Mirati
Research Funding - Revolution Medicines, Verastem, Kinnate, Strategia
Expert Testimony - AstraZeneca
 
Collin M. Blakely
Honoraria - Aptitude Health; Axiom Healthcare Strategies; Clarion Healthcare; Equinox Group
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb/Pfizer; Gilead Sciences; Janssen Oncology; Kura Oncology (I); Rigel (I); SERVIER (I)
Research Funding - AstraZeneca (Inst); Cellectis (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst); Spectrum Pharmaceuticals (Inst); Takeda (Inst); Verastem (Inst)